Meetin an Agressive Go-To-Clinic Timeline
Download Full Case Study
Enteric-Protected Solid Oral Dosage Form Development
Download Full Case Study Abstract: This comprehensive case study offers an exhaustive examination into the precise development of an enteric-protected solid oral…
Development of a Multi-API (Multiparticulate) Fixed-Dose Combination Drug
Abstract: This case study provides a deep dive into Hycon’s achievement in developing a multi-API (Active Pharmaceutical Ingredient) fixed-dose combination oral drug,…
Handling & Production of Scheduled Substances
Executive Summary In this detailed exploration, We explore the detailed journey of Hycon pharma solutions, a global pharmaceutical powerhouse, in their quest…
ODT formulation For Pediatrics
1. Expanded Company Background and Project Objective Employees: 300, including 50 PhDs in pharmaceutical sciences, pharmaceutics, and medicinal chemistry Capabilities: Equipped with state-of-the-art R&D…
Analytical Method Optimization Based on Quality by Design
Quality by Design (QbD) is a well-known pharmaceutical industry strategy for enhancing production processes, including active pharmaceutical ingredients and medicinal products. Companies…
Improving Therapeutic Compound Oral Bioavailability
Poor solubility remains an ongoing challenge in formulation development. Dr. Sridhar Gummudaveli, Director R &D shares insights on lipid-based drug-delivery systems to…
Early Phase Development Using Integrated Solutions
A newly formed pharmaceutical company was creating a novel cardiometabolic drug, a new small molecule, that was in Phase 2a testing in…
